3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
29
Myelodysplastic Syndromes
10
Advanced Solid Tumors
8
Leukemia, Myelomonocytic, Chronic
6
Myeloproliferative Disorders
5
Advanced Solid Tumor
5
Ovarian Neoplasms
4
Neoplasms
4
Lung Neoplasms
4
Advanced Solid Tumour
4
Small Cell Lung Carcinoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Leukemia, Monocytic, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Thrombocythemia, Essential
2
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumor
2
Recurrence
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Neoplasm Metastasis
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Biphenotypic, Acute
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Interventions
Carboplatin
4
pembrolizumab
3
durvalumab
2
Pemetrexed
2
Paclitaxel
2
Cisplatin
2
selpercatinib
1
repotrectinib
1
pralsetinib
1
efineptakin alfa
1
ceralasertib
1
atezolizumab
1
Nivolumab
1
Kyphoplasty
1
Gemcitabine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thoracic Neoplasms
×
Injections
×
90 days
×
Clear all
No trials found.